Aspira Pathlab & Diagnostics Limited has submitted a regulatory filing to BSE Limited's Listing Department intimating a change in the promoter category of the company.
The disclosure is made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The change is a direct consequence of the completion of an Open Offer made under the provisions of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
Key Changes in Promoter Classification:
- Mr. Nikunj Mange, who was previously associated with the company in the capacity of a Director, has now been classified as a Promoter of the company following the completion of the Open Offer.
- Mr. Jay Arvind Bhanushali, who was not a promoter of the company prior to this Open Offer, has also been newly classified as a Promoter of the company.
Effective Date: The change in promoter classification became effective immediately upon the completion of the Open Offer process.
Regulatory Basis: The reclassification is in accordance with the applicable provisions of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 and other applicable laws.
The letter was digitally signed by Nikunj Velji Mange, Executive Director (DIN: 08489442), on behalf of Aspira Pathlab & Diagnostics Limited on June 11, 2026.